Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-05-01

Clinical Trial Update: Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans [Phase 1]

View source ↗

Summary

Phase 1 study at Massachusetts General Hospital investigating genetic factors that influence the acute response to metformin and glipizide in adults with type 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glipizide (Glipizide)
  • metformin (metformin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-05-01